Cottage cheese is not an inflammatory food. The best available evidence suggests dairy products, including cheese, are either neutral or mildly anti-inflammatory for most people. A meta-analysis of 11 randomized controlled trials with 663 participants found that higher dairy consumption reduced several key inflammation markers compared to low or no dairy intake, including C-reactive protein (CRP), tumor necrosis factor-alpha, and interleukin-6. That said, a few factors like sodium content, added thickeners, and individual sensitivities can shift the picture for certain people.
What the Research Shows About Dairy and Inflammation
The idea that dairy drives inflammation has been popular in wellness circles for years, but clinical trials tell a different story. The meta-analysis of randomized controlled trials found that high dairy consumption lowered CRP by 0.24 mg/L and IL-6 by 0.74 pg/mL compared to people eating little or no dairy. These are modest reductions, but they point in the opposite direction from what many people assume. The researchers concluded that their findings “highlight the probable anti-inflammatory properties of dairy products.”
A large cross-sectional study of over 26,000 postmenopausal women looked specifically at cheese intake and found that women who ate the most cheese had about 5% lower CRP and 5.2% lower IL-6 levels compared to those who ate the least. Full-fat cheese (a category that included cottage cheese and ricotta) was independently associated with 3.4% lower CRP. The same study found cheese intake was linked to lower fasting glucose and insulin levels, which matters because chronically elevated insulin can itself fuel inflammatory pathways.
One important caveat: when that meta-analysis limited its analysis to the most rigorous study designs (crossover trials, where the same people serve as their own control group), the anti-inflammatory benefit disappeared. So while cottage cheese almost certainly doesn’t promote inflammation, the strength of its anti-inflammatory effect is still debated.
Why Cottage Cheese Fares Better Than Other Dairy
Not all dairy products behave the same way in the body. The postmenopausal women’s study found that butter was associated with unfavorable biomarker profiles, while cheese and yogurt were associated with favorable ones, despite similar saturated fat content. This suggests something beyond fat content is at work. Cheese contains a complex mix of proteins, calcium, and fermentation byproducts that may offset the effects of its saturated fat.
Cottage cheese has a few specific advantages. It’s high in protein (roughly 12 to 14 grams per half cup) and relatively low in fat, especially in reduced-fat versions. It also contains the least sodium of any common cheese variety, averaging about 220 mg per 100 grams. For context, cheddar and processed cheeses often contain two to three times that amount. Since excessive sodium intake is linked to elevated blood pressure and cardiovascular strain, cottage cheese’s lower sodium profile is a meaningful plus. Still, 220 mg per 100 grams adds up if you’re eating large portions, so it’s worth checking labels if you’re watching your salt intake.
The A1 Casein Question
One legitimate concern about dairy and inflammation involves a protein called A1 beta-casein. Most conventional cow’s milk contains a mix of A1 and A2 beta-casein proteins. When your body digests A1 beta-casein, it can release a fragment called BCM-7 that has been shown to promote intestinal inflammation and worsen gastrointestinal symptoms in some people. A controlled study of 45 adults with self-reported milk intolerance found that conventional milk (containing both A1 and A2 casein) increased small intestine inflammation, raised serum inflammatory biomarkers, and slowed gut transit time compared to milk containing only A2 casein.
Most commercial cottage cheese is made from conventional milk containing A1 beta-casein. If you notice digestive discomfort, bloating, or other symptoms after eating cottage cheese, this protein type could be a factor. Some brands now use A2 milk, which may be worth trying if you suspect sensitivity. That said, this research applies to a subset of people who are already sensitive to dairy. It doesn’t mean A1 casein causes inflammation in everyone.
Watch for Thickeners and Additives
The cottage cheese itself isn’t the only thing in the container. Lower-fat versions commonly contain thickeners like carrageenan and guar gum to improve texture. Carrageenan in particular has drawn scrutiny for its potential effects on gut lining integrity, though the evidence in humans at typical dietary levels remains limited. Full-fat cottage cheese can contain these additives too.
If you want to minimize your exposure, check the ingredient list. Brands with shorter ingredient lists (cultured milk, cream, salt, and maybe a starter culture) exist at most grocery stores. Some people who react poorly to one brand of cottage cheese do fine with another, and the additive profile is often the variable that changes.
Who Might Want to Be Cautious
For the general population, cottage cheese appears to be either neutral or mildly beneficial when it comes to inflammation. But a few groups may want to pay closer attention. People with a confirmed dairy allergy have an immune-mediated inflammatory response to milk proteins, and cottage cheese will trigger that regardless of its other properties. People with lactose intolerance may experience gut irritation that could contribute to local inflammation, though cottage cheese contains less lactose than milk.
People with irritable bowel syndrome or other conditions involving gut sensitivity may find that cottage cheese worsens symptoms, potentially through the A1 casein mechanism described above or through reaction to additives. In these cases, the inflammation isn’t caused by cottage cheese being inherently inflammatory. It’s caused by an individual reaction in a sensitive digestive system.
For most people eating a balanced diet, cottage cheese is a high-protein, relatively low-sodium dairy food that the current evidence links to lower, not higher, levels of circulating inflammatory markers.